drugset / Trial / NCT02410083

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

NCT02410083 ↗

Phase 4 Completed 448 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study in to evaluate efficacy and tolerability of Clopirin and clopidogrel with aspirin in Korean Patients with post-percutaneous coronary artery intervention.

Timeline

Start
2012-11
Primary completion
2013-04
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule — —
Comparator Clopidogrel Small molecule — —
Subject Clopirin Unknown — —

Indications